Recognizing the month of November 2026 as "National Epilepsy Awareness Month" in Pennsylvania.
Summary
House Resolution 518 is a commemorative resolution that recognizes November 2026 as "National Epilepsy Awareness Month" in Pennsylvania. The resolution explains what epilepsy is, describes seizures and their neurological basis, and highlights the prevalence of epilepsy in the United States, including the number of people affected, annual new diagnoses, and the risks associated with seizures and sudden unexplained death in epilepsy.
The resolution also acknowledges the work of the Epilepsy Association of Western and Central Pennsylvania and the Epilepsy Foundation of Eastern Pennsylvania, noting their long-standing service to Pennsylvanians since 1972 and their role in education, advocacy, and support for people living with epilepsy. It emphasizes that awareness and education can help reduce stigma, improve understanding, and support quality of life for individuals with epilepsy and seizures.
Impact
This resolution does not change substantive state law, create a regulatory program, or appropriate funds. Its legal effect is limited to an official House recognition of November 2026 as National Epilepsy Awareness Month in Pennsylvania, which may be used to support public awareness efforts, educational outreach, and advocacy by state agencies, nonprofits, schools, and health organizations.
Sentiment
The bill appears to have broad, noncontroversial support. It was reported from the House Health Committee by a unanimous 26-0 vote, and there is no recorded opposition or committee debate in the provided materials. The tone of the resolution is supportive and informational, focused on public awareness and recognition of affected individuals and advocacy organizations.
Contention
No notable points of contention are reflected in the available record. Because the measure is a symbolic awareness resolution rather than a policy or funding bill, there is little indication of disagreement over implementation, costs, or legal consequences. The only substantive emphasis is on the importance of combating misinformation and stigma surrounding epilepsy, which is presented as a shared public-health goal rather than a disputed issue.